The best of echocardiography in 2000;L'essentiel de 2000 en échocardiographie

Archives des Maladies du Coeur et des Vaisseaux

Volumn 94, Issue SPEC. ISS, 2001, Pages 27-39

  Cohen, A ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

CARDIOVASCULAR DISEASE; CONTINUOUS INFUSION; CONTRAST ECHOCARDIOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; EVALUATION; HEART CATHETERIZATION; HEART FUNCTION; HEART MUSCLE PERFUSION; HUMAN; IMAGE PROCESSING; PROGNOSIS; REVIEW; STRESS ECHOCARDIOGRAPHY; TRAINING; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VALIDATION PROCESS;

ATRIAL FIBRILLATION; CORONARY CIRCULATION; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TEST; HEART DISEASES; HEART FAILURE, CONGESTIVE; HEART VALVE DISEASES; HUMANS; VENTRICULAR FUNCTION;

EID: 17444450710     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. L'essentiel de 1999 en échocardiographie
2. Transthoracic echocardiography using second harmonic imagining. Diagnostic alternative transoesophageal echocardiography for the detection of atrial rate to left lunch in patients with cerebral embolic events
3. Percutaneous detection of protruding aortic atheromas by suprasternal harmonic imaging
4. Non-contrast second harmonic imaging improves interobserver agreement and accuracy of dobutamine stress echocardiography in patients with impaired image quality
5. Maturing of stress echocardiography: Improved agreement on interpretation of dobutamine stress echocardiography using new techniques
6. Safety of dobutamineotropine stress echocardiography: A prospective experience of 4,033 consecutive studies
7. Comparison of bicycle, heavy isometric, dipyridamole-atropine and dobutamine stress echocardiography for diagnosis of myocardial ischemia
8. The comparable diagnostic accuracies of dobutamine-stress and dipyridamole-stress echocordiographies: A meta-analysis
9. Exercise echocardiography versus exercise electrocardiography in the diagnosis of the coronary artery disease in hypertension
10. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test
11. Low-level exercise echocardiography detectes contractile reserve and predicts reversible dysfunction after acute myocardial infarction: Comparison with low-dose dobutamine echocardiography
12. Comparison of dobutamine echocardiography, dobutamine sestamibi, and rest-redistribution thallium-201 single-photon emission computed tomography for determining contractile reserve and myocardial ischemia in ischemic cordiomyopathy
13. Pronostis of myocardial ischemia and viability in patients with chronic ventricular ischemic dysfunction
14. Prediction of global left ventricular function after bypas surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism
15. Prognostic value of myocardial viability testing: A meta-analysis
16. Pronostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: A prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test
17. Prediction of cardiac events after uncomplicated acute myocardial infarction by clinical variables and dobutamine stress test
18. Can dobutamine stress echocardiography predict cardiac events in nonrevascularized diabetic patients following acute myocardial infarction?
19. Safety and pronostic volue of early dobutamine-atropine stress echocardiography in patients with spontaneous chest pain and a non-diagnostic: Electrocardiogramm
20. Feasibility and pronostic value of dobutamine-atropine stress echocardiography early in unstable angina
21. Assessment of cardiac risk before nanvascular surgery: Dobutamine stress echocardiography in 530 patients
22. Perioperative prognostic value of dipyridamale echocardiography in vascular surgery: A largescale multicenter study in 509 patients
23. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch echocardiographic cardiac risk evaluation applying a stress echocardiography study group
24. Long-term prognostic value of dobutamine stress echocardiography after successful major vascular surgery
25. Assessment of nonuniformity of transmural myocardial velocities by color-coded tissue Doppler imaging: Characterization of normal, ischemic, and stunned myocardium
26. Quantitative systolic and diastolic transmyocardial velocity gradients assessed by M-mode colour Doppler tissue imaging as reliable indicators of regional left ventricular function after acute myocardial infarction
27. Used of piek systolic strain rate and index of regional left ventricular function: Comparison with tissue Doppler velocity during dobutamine stress and myocardial ischemia
28. Quantitation of the long axis during stress echo. Which marker can best predict presence of coronory artery disease?
29. Regional diastolic function by pulsed Doppler myocardiol mapping for the detection of left ventricular ischemia during pharmacologic stress testing: A comparison with stress echocardiography and perfusion scintigraphy
30. Is the technically and echocardiogrophic study and endangered species? Endocardiol border definition with native tissue harmonic imaging and optisons contrast: Euro view of 200 cases
31. Assessment of myocardial reperfusion by intravenous mycardial contrast echocardiography and coronary flow reserve after primary percutoneaus transluminal coronary angiography in patients with acute myocardial infarction
32. Differentiation between restrictive cardiomyopathy and constrictive pericarditis by early diastolic Doppler myocardial velocity gradient at the posterior wall
33. Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (the PRESERVE Study)
34. Relation of left ventricular diastolic properties to systolic function in arterial hypertension
35. Beta-blockade therapy in chronic heart failure: Diastolic function and mitral regurgitation improvement by carvedilol
36. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction
37. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction
38. Echocardiographic findings in fulminant and acute myocarditis
39. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy
40. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy
41. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy
42. Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
43. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
44. Prevalence and clinical outcome of mitral-valve prolapse
45. Lack of evidence of an association between mitral-valve prolapse and stroke in young patients
46. Functional anatomy of mitral regurgitation: Accuracy and outcome implications of transesophageal echocardiography
47. Mortality and morbidity of aortic regurgitation clinical practice. Long-term follow-up study
48. Assessment of severity of aortic regurgitation using the width of the vena contracta: A clinical color doppler imaging study
49. Quantification of tricuspid regurgitation by measuring the width of the vena contracta with Doppler color flow imaging: A clinical study
50. Clinical characteristics of a familial inherited myxomatous valvular dystrophy mapped to Xq28
51. Fenfluramine and phentermine and cardiovascular findings: Effect of treatment duration on prevalence of valve abnormalities
52. Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine
53. Does the severity of appetite-suppressant-related aortic valve insufficiency change over time after stopping exposure to drug?
54. Predictors of outcome in severe asymptomatic aortic stenosis
55. New insights into the progression of aortic stenosis implication for the secondary prevention
56. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity n the elderly
57. Aortic valve replacement in patients with aortic stenosis and severe left ventricular dysfunction
58. Echocardiographie-Doppler sous dobutamine et sténose aortique sévère avec dysfonction ventriculaire gauche: Comparaison avec le suivi postopératoire
59. Flow convergence flow rates from 3-dimensional reconstruction of color Doppler flow maps for computing transvalvular regurgitant flows without geometric assumptions: An in vitro quantitative flow study
60. Design of a new surgical approach for ventricular remodeling to relieve ischemic mitral regurgitation: Insights from 3-dimensional echocardiography
61. Influence of atrial septal defect anatomy, in patient selection and assessment of closure with the Cardiaseal device; a three-dimensional transoesophageal echocardiographic reconstruction
62. Dynamic morphology of the secondum atrial septal defect evaluated by three dimensional transoesophageal echocardiography
63. Usefulness of three-dimensional echocardiography for the evaluation of mitral valve prolapse: An intraoperative study
64. Structural remodeling of the left atrial appendage in patients with chronic non-valvular atrial fibrillation: Implications for thrombus formation, systemic embolisms and assessment by transoesophageal echocardiography
65. Mechanical remodeling of the left atrium after loss of atrioventricular synchrony. A long-term study in humans
66. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study)
67. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study)
68. Clinical and echocardiographic characteristics of left atrial spontaneous echo contrast in sinus rhythm
69. The assessment of cardioversion using TEE. ACUTE muticenter trial: Rhythm outcome as a secandary endpoint after 8-week follow-up
70. Embolic risk based on aortic atherosclerotic morphologic features and aortic spontaneous echocardiographic contrast
71. Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: Benefit of oral anticoagulants
72. Warfarin therapy and risk of embolic events in stroke patients with aortic atheromas
73. Protruding aortic arch atheromas: Risk of stroke during heart surgery with and without aortic arch endarterectomy
74. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism
75. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events
76. Significant association of atrial vulnerability with atrial septol abnormalities in young patients with ischemic stroke of unknown cause